Pytte Morten, Kramer-Johansen Jo, Eilevstjønn Joar, Eriksen Morten, Strømme Taevje A, Godang Kristin, Wik Lars, Steen Petter Andreas, Sunde Kjetil
Department of Anaesthesiology, Ulleval University Hospital, Oslo, Norway.
Resuscitation. 2006 Dec;71(3):369-78. doi: 10.1016/j.resuscitation.2006.05.003. Epub 2006 Oct 4.
Adrenaline (epinephrine) is used during cardiopulmonary resuscitation (CPR) based on animal experiments without supportive clinical data. Clinically CPR was reported recently to have much poorer quality than expected from international guidelines and what is generally done in laboratory experiments. We have studied the haemodynamic effects of adrenaline during CPR with good laboratory quality and with quality simulating clinical findings and the feasibility of monitoring these effects through VF waveform analysis.
After 4 min of cardiac arrest, followed by 4 min of basic life support, 14 pigs were randomised to ClinicalCPR (intermittent manual chest compressions, compression-to-ventilation ratio 15:2, compression depth 30-38 mm) or LabCPR (continuous mechanical chest compressions, 12 ventilations/min, compression depth 45 mm). Adrenaline 0.02 mg/kg was administered 30 s thereafter. Plasma adrenaline concentration peaked earlier with LabCPR than with ClinicalCPR, median (range), 90 (30, 150) versus 150 (90, 270) s (p = 0.007), respectively. Coronary perfusion pressure (CPP) and cortical cerebral blood flow (CCBF) increased and femoral blood flow (FBF) decreased after adrenaline during LabCPR (mean differences (95% CI) CPP 17 (6, 29) mmHg (p = 0.01), FBF -5.0 (-8.8, -1.2) ml min(-1) (p = 0.02) and median difference CCBF 12% of baseline (p = 0.04)). There were no significant effects during ClinicalCPR (mean differences (95% CI) CPP 4.7 (-3.2, 13) mmHg (p = 0.2), FBF -0.2 (-4.6, 4.2) ml min(-1)(p = 0.9) and CCBF 3.6 (-1.8, 9.0)% of baseline (p = 0.15)). Slope VF waveform analysis reflected changes in CPP.
Adrenaline improved haemodynamics during laboratory quality CPR in pigs, but not with quality simulating clinically reported CPR performance.
基于动物实验,肾上腺素被用于心肺复苏(CPR),但缺乏支持性临床数据。最近有临床报告称,CPR的质量比国际指南预期的以及实验室实验中通常所做的要差得多。我们研究了在高质量实验室条件下以及模拟临床结果的条件下,肾上腺素在CPR期间的血流动力学效应,以及通过室颤波形分析监测这些效应的可行性。
在心脏骤停4分钟后,进行4分钟的基础生命支持,14头猪被随机分为临床CPR组(间歇性手动胸外按压,按压与通气比例为15:2,按压深度30 - 38毫米)或实验室CPR组(持续机械胸外按压,每分钟通气12次,按压深度45毫米)。此后30秒给予0.02毫克/千克的肾上腺素。实验室CPR组血浆肾上腺素浓度峰值出现得比临床CPR组更早,中位数(范围)分别为90(30,150)秒和150(90,270)秒(p = 0.007)。在实验室CPR期间,给予肾上腺素后冠状动脉灌注压(CPP)和大脑皮质血流(CCBF)增加,股动脉血流(FBF)减少(平均差异(95%置信区间):CPP为17(6,29)毫米汞柱(p = 0.01),FBF为 - 5.0(- 8.8,- 1.2)毫升/分钟(p = 0.02),CCBF中位数差异为基线的12%(p = 0.04))。在临床CPR期间无显著影响(平均差异(95%置信区间):CPP为4.7(- 3.2,13)毫米汞柱(p = 0.2),FBF为 - 0.2(- 4.6,4.2)毫升/分钟(p = 0.9),CCBF为基线的3.6(- 1.8, 9.0)%(p = 0.15))。室颤波形斜率分析反映了CPP的变化。
肾上腺素在猪的高质量实验室CPR期间改善了血流动力学,但在模拟临床报告的CPR表现时未起到改善作用。